RTN4 and ischemic stroke: In addition, toxic metabolites, such as amyloid-beta and Nogo-A, which are produced during the progression of ischemic stroke and get deposited in the brain parenchyma, could result in secondary degeneration with neuronal death and poor neurological outcomes with memory function impairment [48,49,50].